1. Home
  2. FEMY vs INLX Comparison

FEMY vs INLX Comparison

Compare FEMY & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.50

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$8.00

Market Cap

36.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
INLX
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
36.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FEMY
INLX
Price
$0.50
$8.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.83
N/A
AVG Volume (30 Days)
1.1M
3.6K
Earning Date
03-26-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,061,502.00
$16,539,674.00
Revenue This Year
$64.02
N/A
Revenue Next Year
$147.19
$15.82
P/E Ratio
N/A
N/A
Revenue Growth
63.53
N/A
52 Week Low
$0.31
$7.50
52 Week High
$1.80
$15.72

Technical Indicators

Market Signals
Indicator
FEMY
INLX
Relative Strength Index (RSI) 37.70 45.82
Support Level $0.48 $7.95
Resistance Level $0.54 $8.51
Average True Range (ATR) 0.04 0.09
MACD -0.00 0.03
Stochastic Oscillator 15.19 23.88

Price Performance

Historical Comparison
FEMY
INLX

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: